ES8703437A1 - Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados - Google Patents

Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados

Info

Publication number
ES8703437A1
ES8703437A1 ES550879A ES550879A ES8703437A1 ES 8703437 A1 ES8703437 A1 ES 8703437A1 ES 550879 A ES550879 A ES 550879A ES 550879 A ES550879 A ES 550879A ES 8703437 A1 ES8703437 A1 ES 8703437A1
Authority
ES
Spain
Prior art keywords
lower alkyl
hydrogen
benzoxazin
ones
nhr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550879A
Other languages
English (en)
Other versions
ES550879A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/673,996 external-priority patent/US4657893A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES550879A0 publication Critical patent/ES550879A0/es
Publication of ES8703437A1 publication Critical patent/ES8703437A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C07C265/16—Derivatives of isocyanic acid having isocyanate groups acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
    • C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
    • C07C273/1827—X being H
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 4H-3,1-BENZOXAZIN-4-ONAS, DE FORMULA (I) Y DE SUS SALES Y ESTERES FISIOLOGICAMENTE COMPATIBLES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA RNH2 O AOR1 PARA FORMAR EL COMPUESTO DE FORMULA (I), EN LAS QUE R1 REPRESENTA HIDROGENO O ALQUILO Y R, R2, R3 Y X PUEDEN SER VARIOS TIPOS DE RADICALES; SEGUIDA DE LA SEPARACION DE LA MEZCLA RESULTANTE SIGUIENDO TECNICAS CONVENCIONALES. LA REACCION SE EFECTUA EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE, A UNA TEMPERATURA COMPRENDIDA ENTRE C10JC Y 10JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO INHIBIDORES DE ENZIMAS.
ES550879A 1983-12-27 1986-01-14 Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados Expired ES8703437A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56612983A 1983-12-27 1983-12-27
US60860984A 1984-05-09 1984-05-09
US06/673,996 US4657893A (en) 1984-05-09 1984-11-26 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors

Publications (2)

Publication Number Publication Date
ES550879A0 ES550879A0 (es) 1987-03-01
ES8703437A1 true ES8703437A1 (es) 1987-03-01

Family

ID=27415984

Family Applications (2)

Application Number Title Priority Date Filing Date
ES539038A Expired ES8607260A1 (es) 1983-12-27 1984-12-26 Procedimiento para la preparavion de 4h-3, l-benzoxazin-4-onas y compuestos relacionados
ES550879A Expired ES8703437A1 (es) 1983-12-27 1986-01-14 Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES539038A Expired ES8607260A1 (es) 1983-12-27 1984-12-26 Procedimiento para la preparavion de 4h-3, l-benzoxazin-4-onas y compuestos relacionados

Country Status (11)

Country Link
EP (1) EP0147211B1 (es)
KR (1) KR890000992B1 (es)
CA (1) CA1269800A (es)
DE (1) DE3483204D1 (es)
DK (1) DK625184A (es)
ES (2) ES8607260A1 (es)
FI (1) FI79842C (es)
HU (1) HU195648B (es)
IL (1) IL73943A (es)
NO (1) NO163184C (es)
NZ (1) NZ210669A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
ES2067140T3 (es) * 1990-09-10 1995-03-16 Asahi Chemical Ind Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos.
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
US5985872A (en) * 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections
GB9700597D0 (en) * 1997-01-14 1997-03-05 Sandoz Pharma Uk Organic compounds
US6180625B1 (en) 1998-03-24 2001-01-30 Novo Nordisk A/S Heterocyclic compounds regulating clotting
AU2826099A (en) * 1998-03-24 1999-10-18 Novo Nordisk A/S Heterocyclic compounds regulating clotting
WO2000030646A1 (en) * 1998-11-26 2000-06-02 Novo Nordisk A/S Heterocyclic compounds regulating clotting
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
EP1147091A2 (en) 1999-01-22 2001-10-24 Elan Pharmaceuticals, Inc. Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
NZ529822A (en) 1999-01-22 2005-11-25 Elan Pharm Inc Acyl derivatives which treat VLA-4 related disorders
US6436904B1 (en) 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
CN101273035A (zh) 2005-09-29 2008-09-24 伊兰制药公司 抑制由vla-4介导的白细胞粘附的氨基甲酸酯化合物
DK1940826T3 (da) 2005-09-29 2011-04-18 Elan Pharm Inc Pyrimidinylamidforbindelser, der inhiberer leukocytadhæsion medieret gennem BLA-4
MX2008010988A (es) 2006-02-27 2008-10-20 Elan Pharm Inc Compuestos de pirimidinil sulfonamida que inhiben la adhesion de los leucocitos mediada por vla-4.
CA2760151A1 (en) 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
US20200109126A1 (en) * 2017-01-06 2020-04-09 The Regents Of The University Of California Mu opioid receptor modulators
AU2019247842B2 (en) 2018-04-04 2023-08-31 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto
TW202304869A (zh) 2021-04-05 2023-02-01 美商艾碧奧戴股份有限公司 類鴉片受體調節劑

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450700A (en) * 1966-12-20 1969-06-17 Upjohn Co 2-tertiary amino-4h-3,1-benzoxazin-4-ones
DE2315303A1 (de) * 1973-03-27 1974-10-17 Bayer Ag Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen

Also Published As

Publication number Publication date
IL73943A0 (en) 1985-03-31
ES550879A0 (es) 1987-03-01
HUT36808A (en) 1985-10-28
DE3483204D1 (de) 1990-10-18
FI79842C (fi) 1990-03-12
EP0147211B1 (en) 1990-09-12
KR890000992B1 (ko) 1989-04-15
EP0147211A3 (en) 1985-08-14
FI845116L (fi) 1985-06-28
EP0147211A2 (en) 1985-07-03
NO163184C (no) 1990-04-18
DK625184A (da) 1985-06-28
DK625184D0 (da) 1984-12-21
ES539038A0 (es) 1986-06-01
IL73943A (en) 1989-01-31
CA1269800A (en) 1990-05-29
ES8607260A1 (es) 1986-06-01
HU195648B (en) 1988-06-28
FI79842B (fi) 1989-11-30
NZ210669A (en) 1988-05-30
NO845176L (no) 1985-06-28
FI845116A0 (fi) 1984-12-27
KR850004472A (ko) 1985-07-15

Similar Documents

Publication Publication Date Title
ES8703437A1 (es) Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados
IL80270A0 (en) Naphthalene derivatives,their preparation and pharmaceutical compositions containing them
FI96857B (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista tiatsoliyhdistettä
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
NZ221112A (en) Bicyclic aromatic compounds and pharmaceutical compositions
ZA909901B (en) Peptide compounds,a process for preparation thereof and pharmaceutical composition comprising the same
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
ES8402272A1 (es) Procedimiento para la preparacion de aminoacidos ciclicos o esteres de los mismos.
KR880007461A (ko) 헤테로 사이클-치환 디포스포네이트화합물 및 이의 약제학적 조성물
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
EP0228845A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ZA908131B (en) Gem-diphosphonic acids,a process for the preparation thereof and pharmaceutical compositions containing them
ES8201576A1 (es) Procedimiento para la obtencion de compuestos de acido di- glicidil-isocianurico n-sustituidos
IL141920A0 (en) Process for the preparation of alkyl mercapto methyl ergoline derivatives
ES525684A0 (es) Procedimiento para preparar derivados de prolina
ES8801227A1 (es) Procedimiento para preparar derivados de benzazol
ES8606780A1 (es) Procedimiento para preparar composiciones herbicidas sinergisticas a base de n-fosfonometilglicina
EA200100677A1 (ru) Производные 6-азаурацила, ингибирующие il-5
MX2023006324A (es) Mezclas de n-acil alaninatos y otros surfactantes de n-acil aminoacido y derivados de estos.
GR3002560T3 (en) 2-selenomethyl-1, 4-dihydropyridines, a process for the preparation thereof and pharmaceutical compositions containing them
ZA905924B (en) N-(23-vincristinoyl)and n-(5'-noranhydro-23-vinblastinyol)derivatives of 1-aminomethylphosphonic acid,process for preparing these and pharmaceutical compositions containing them
MX9604610A (es) Derivados ester y carbamato de azolonas anti- helicobacter
GB1490269A (en) Substituted 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepines and acid addition salts thereof